• SENSEX 74,820.07
    290.99 (+0.39%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Meesho
    230.80 125.70(%)
  • Allied Blenders
    667.75 719.95(%)
  • Escorts Kubota
    2,828.00 3,998.95(%)
  • Molbio Diagnosti
    1,335.65 1,686.50(%)
  • Swiggy
    279.80 235.85(%)
  • Kanohar Elect.
    938.00 905.50(%)
  • Ola Electric
    42.32 59.20(%)
  • Tour. Fin. Corp.
    143.00 148.00(%)
  • Glass Wall Syst.
    296.00 185.05(%)
  • Eternal
    344.75 368.40(%)
  • HDFC Bank
    741.85 1,020.35(%)
  • PC Jeweller
    14.87 14.45(%)
  • Cholaman.Inv.&Fn
    1,783.85 1,952.00(%)
  • Cupid
    264.00 298.95(%)
  • Transrail Light
    469.30 401.00(%)
  • Kotak Mah. Bank
    417.15 452.98(%)
  • Wockhardt
    2,359.60 2,420.00(%)
  • Solar Industries
    20,362.20 22,630.05(%)
  • Ather Energy
    1,484.00 535.00(%)
  • Supreme Inds.
    3,501.00 4,436.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Amrutanjan Health Care Ltd Pharmaceuticals - Indian - Formulations

  • Amrutanjan
  • BSE Code : 17.0
  • ISIN : INE098F01031
500.05 4 (0.81%)
  • As on 23 Sep 2026 (EOD)
  • Today’s Low

    493.40
  • Today’s High

    504.00
  • Open

    493.40
  • Perv Close

    496.05
  • 52W Low

    476.50
  • 52W High

    772.00

Key Indicators

  • P/E(TTM)

    23.25

  • Mar.Cap (₹Cr.)

    1,445.68

  • Div & Yield %

    0.98

  • Book Value(₹)

    128.06

  • Debt-Equity Ratio

    0.81

  • AGM Date

    22-Sep-2026

  • EPS

    21.52

  • P/E Ratio

    23.25

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1,445.68

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    2.89

  • BV (₹)

    128.10

  • Sales( ₹ in Cr.)

    502.55

  • NP (in Cr.)

    64.18

  • NP Var(%)

    26.0

  • Div%

    490.0

  • CPS (₹)

    24.40

  • EPS (₹)

    22.20

  • Traded Value (₹ in Lakhs)

    1,446.25

  • 52 Week High

    772.00

  • 52 Week Low

    476.50

  • Price BSE

    500.0

  • Price NSE

    500.00

  • Market Capital( in Cr.)

    1,446.25

  • P/C Ratio

    20.50

  • P/E Ratio

    22.50

  • Price Vs.BV

    22.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 502.55 451.82 421.23 379.64 405.84 332.84
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 502.55 451.82 421.23 379.64 405.84 332.84
Other Income 17.57 17.68 16.35 14.54 15.38 11.32
Stock Adjustments 2.70 0.57 -2.15 1.73 5.50 -5.01
Total Income 522.82 470.07 435.43 395.91 426.72 339.15
EXPENDITURE :            
Raw Materials 247.06 223.78 209.67 183.71 185.96 135.18
Power and Fuel Cost 3.73 3.52 3.84 3.06 2.66 1.76
Employee Cost 63.76 59.10 47.69 48.81 48.23 41.70
Other Manufacturing Expenses 12.24 10.96 9.86 10.38 8.37 6.66
Selling and Administration Expenses 97.28 92.02 89.23 86.95 84.68 64.72
Miscellaneous Expenses 14.18 4.70 6.87 3.92 1.87 2.97
Employee Benefit Expenses 63.76 59.10 47.69 48.81 48.23 41.70
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 438.25 394.08 367.17 336.83 331.77 252.99
Operating Profit 84.58 75.99 68.25 59.08 94.95 86.16
Interest 0.37 0.33 0.25 0.22 0.58 0.59
Gross Profit 84.21 75.66 68.00 58.86 94.37 85.57
Depreciation 6.32 6.53 6.06 5.21 3.80 3.67
Profit Before Tax 77.89 69.13 61.94 53.65 90.57 81.90
Current Tax 22.13 17.97 15.94 14.01 23.39 19.73
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.16 0.33 1.03 -0.20 0.00 0.98
Reported Net Profit 57.92 50.83 44.97 39.83 67.19 61.19
Extraordinary Items -6.27 0.00 0.11 0.02 0.01 0.07
Adjusted Net Profit 64.19 50.83 44.86 39.81 67.18 61.12
Adjustment below Net Profit -0.14 -0.79 -35.32 0.00 0.00 0.00
P & L Balance brought forward 272.96 236.21 239.89 214.72 161.62 105.13
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.30 13.30 13.33 14.67 14.08 4.71
P & L Balance carried down 317.44 272.96 236.21 239.89 214.72 161.62
Dividend 0.00 0.00 0.00 0.00 5.85 4.68
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 490.00 460.00 460.00 460.00 460.00 420.00
Dividend Per Share(Rs) 4.90 4.60 4.60 4.60 4.60 4.20
Earnings Per Share-Unit Curr 20.03 17.58 15.56 13.63 22.99 20.93
Earnings Per Share(Adj)-Unit Curr 20.03 17.58 15.56 13.63 22.99 20.93
Book Value 128.06 112.97 99.78 99.47 90.70 73.75
Book Value(Adj)-Unit Curr 128.06 112.97 99.78 99.47 90.70 73.75

Shareholding Pattern

  • Promoter Group

    46.52%

  • Public Share Holding

    53.45%

  • Custodian

    0.04%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 10,918,703 37.77 10,918,703 4
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,529,487 8.75 2,529,487 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 13,448,190 46.52 13,448,190 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 25,460 0.09 24,960 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 704,823 2.44 704,823 31
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,682,578 5.82 1,682,578 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,843,400 6.38 1,843,400 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,256,261 14.72 4,255,761 47
2] Non Institution
Bodies Corporate 461,785 1.60 460,265 168
Clearing Members 128 0.00 128 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 496,500 1.72 496,180 1,062
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 375,244 1.30 375,240 725
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 870,703 3.01 870,703 3
Individuals holding nominal share capital up to Rs. 1 lakh 8,398,467 29.05 8,011,151 43,095
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 6,170 0.02 6,170 1
Others 438,226 1.52 435,546 2
Sub Total 11,195,630 38.73 10,803,790 45,080
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 10,549 0.04 10,549 1
Total Shares held by Custodians and against which Depository Receipts have been issued 10,549 0.04 10,549 1
Grand Total ( A + B + C ) 28,910,630 100.00 28,518,290 45,135

Company Background

Amrutanjan Health Care LtdPharmaceuticals - Indian - Formulations

  • Amrutanjan Health Care Ltd
  • BSE Code : 17.0
  • ISIN : INE098F01031
  • Incorporation Year

    1936

  • Registered Office

    New 103 Old 42-45 LuzChurch Rd
    Mylapore, Chennai,
    Tamil Nadu-600004

  • Telephone

    91-44-24994164/24994465/24994366

  • FAX

    91-44-24994585

  • Chairman

    S Sambhuprasad

  • Managing Director

  • Company Secretary

  • Auditor

    B S R & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Amrutanjan Health Care Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Sanofi India 3,056.10 1,857.10 1,837.40 21.74 54.17
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77